Home » Newsletters » BioWorld Science

BioWorld Science

April 23, 1997

View Archived Issues

Genetronics develops electroporation therapy drug delivery system

Oralife reports promising results for diagnostic test for tooth decay

LifeCell reports clinical data on AlloDerm

Oncor's Sunrise Amplification Detection System presented

Hybridon issued patent for pent-enoyl-protected nucleotides

Bayer discloses antiretroviral agents

Novel 5-HT uptake inhibitors from Bristol-Myers Squibb

New agents for postmenopausal syndrome described by Lilly

Ono discloses ICE inhibitors

Comparison of aspirin and pentoxifylline for claudication

Piracetam as an adjuvant to language therapy for aphasia

North American Vaccine's acellular pertussis vaccine approved in Sweden

Buckminsterfullerene photodynamically inactivates enveloped viruses

Phase III results for TS-110 in osteoarthritis

Disposition of AR-177

DA-9601 shows promise for IBD

Antiangiogenic effects of flavopiridol

Positive clinical results for mitoxantrone in multiple sclerosis

Canadian clearance for Naropin

Triptorelin + melatonin for prostate cancer

Further launches for LeukoScan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...